CPT® Code 81210

The CPT® Code 81210 pertains to the molecular genetic testing of the BRAF gene, specifically focusing on the V600 variant(s). This testing is crucial for identifying mutations in the BRAF (B-Raf proto-oncogene, serine/threonine kinase) gene, which are commonly associated with certain types of cancer, including colorectal cancer and melanoma. The BRAF gene encodes a protein that is part of the raf/mil family of serine/threonine protein kinases, which play a significant role in regulating the MAP kinase/ERK signaling pathways. These pathways are essential for various cellular processes, including cell division, differentiation, and secretion. When mutations occur in the BRAF gene, particularly the V600 variant, they can lead to the production of an altered B-Raf protein that is constitutively active. This means that the protein is continuously signaling the cell to grow and divide, which can result in uncontrolled cell proliferation and contribute to the development of cancer. The most prevalent mutation involves the substitution of the amino acid valine with glutamic acid at position 600 of the BRAF gene. Over 30 different mutations of the BRAF gene have been documented, and genetic testing for these mutations is performed to assist in the diagnosis and treatment planning for patients with cancer. Identifying the specific BRAF mutation can guide oncologists in selecting targeted therapies, such as the chemotherapeutic agents dabrafenib, trametinib, and vemurafenib, which are designed to inhibit the activity of the mutated B-Raf protein and improve treatment outcomes for patients.